| 1 |
33671323 | Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach. | 2021 Feb 17 |
1 |
| 2 |
28958730 | Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients. | 2018 Feb |
1 |
| 3 |
30045320 | Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients. | 2018 Jul |
5 |
| 4 |
24406279 | Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. | 2014 |
2 |
| 5 |
23252947 | Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. | 2013 Jan |
1 |
| 6 |
22188362 | Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. | 2012 Jan |
3 |
| 7 |
15292462 | N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7. | 2004 Dec |
5 |